Advance your academic career, collaborate globally, and expand your network—
join now
!
Graduated in Pharmacy-Biochemistry (São Paulo State University – UNESP; 2001). PhD in Biochemistry (University of São Paulo – USP; 2007). Post-Doctorate in Biochemistry, emphasising Energy Metabolism Control (University of São Paulo – USP; 2008). I am currently an Associate Professor at the School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, São Paulo, Brazil, teaching the subjects of Clinical Biochemistry (for students of Pharmacy) and Metabolic Biochemistry (for students of Bioprocess Engineering and Biotechnology). The h-index is 19 (Scopus; 1159 citations). I have research experience in Biochemistry. Our research is focused on the search for bioactive compounds that are able to contrast complications related to diabetes mellitus and obesity, including renal and cardiovascular diseases. In order to deal with these metabolic diseases and their complications, it is essential to understand the changes in biomarkers that are related to (i) the structural and functional damage in various organs and tissues (including kidneys, heart, liver, vascular endothelium, skeletal muscles, adipose tissues, among others), and (ii) the mechanisms of action that promote damage to biomolecules and tissue injuries (including glycoxidative stress, inflammation, apoptosis, among others).
Graduated in Pharmacy-Biochemistry (São Paulo State University – UNESP; 2001). PhD in Biochemistry (University of São Paulo – USP; 2007). Post-Doctorate in Biochemistry, emphasising Energy Metabolism Control (University of São Paulo – USP; 2008). I am currently an Associate Professor at the School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, São Paulo, Brazil, teaching the subjects of Clinical Biochemistry (for students of Pharmacy) and Metabolic Biochemistry (for students of Bioprocess Engineering and Biotechnology). The h-index is 19 (Scopus; 1159 citations). I have research experience in Biochemistry. Our research is focused on the search for bioactive compounds that are able to contrast complications related to diabetes mellitus and obesity, including renal and cardiovascular diseases. In order to deal with these metabolic diseases and their complications, it is essential to understand the changes in biomarkers that are related to (i) the structural and functional damage in various organs and tissues (including kidneys, heart, liver, vascular endothelium, skeletal muscles, adipose tissues, among others), and (ii) the mechanisms of action that promote damage to biomolecules and tissue injuries (including glycoxidative stress, inflammation, apoptosis, among others).
The user has no Co-authors.
You can be the first follower.